mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |